Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8857 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8857 |
High Similarity |
NPD1613 |
Approved |
0.8643 |
High Similarity |
NPD3027 |
Phase 3 |
0.8633 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8571 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8451 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.831 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8239 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.8125 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8071 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8069 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.8049 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8038 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7975 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7958 |
Intermediate Similarity |
NPD4749 |
Approved |
0.795 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7949 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7927 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7927 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7927 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7892 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7862 |
Intermediate Similarity |
NPD37 |
Approved |
0.7826 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7826 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7826 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7826 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7812 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7778 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7738 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7718 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7718 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7679 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7667 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7667 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.766 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7636 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7633 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7619 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7607 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.76 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7544 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7534 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7529 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7516 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7516 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7451 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7451 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7447 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7442 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.744 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7432 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7419 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7415 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7399 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7396 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7396 |
Intermediate Similarity |
NPD27 |
Approved |
0.7386 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7371 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7356 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7356 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7356 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7356 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7356 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7356 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7355 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7355 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7347 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7347 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7341 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7337 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7337 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7333 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7329 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7321 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7314 |
Intermediate Similarity |
NPD7309 |
Approved |
0.729 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.729 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7286 |
Intermediate Similarity |
NPD228 |
Approved |
0.7279 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7267 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7267 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.725 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.725 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7246 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7239 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7216 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7216 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7215 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7215 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7213 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7205 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7205 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7197 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7176 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7176 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7169 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7169 |
Intermediate Similarity |
NPD5929 |
Approved |
0.716 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD7340 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7134 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7125 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7091 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7091 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7089 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7076 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7071 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7066 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7063 |
Intermediate Similarity |
NPD1398 |
Phase 1 |
0.7059 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7044 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7032 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7024 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7024 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7022 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7019 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7018 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7018 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7011 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7007 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7006 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7 |
Intermediate Similarity |
NPD290 |
Approved |
0.6994 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD7843 |
Approved |
0.6982 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6981 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD1375 |
Discontinued |
0.6981 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6981 |
Remote Similarity |
NPD3540 |
Phase 1 |
0.6981 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6981 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.698 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6977 |
Remote Similarity |
NPD6071 |
Discontinued |
0.6968 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6962 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6959 |
Remote Similarity |
NPD5126 |
Approved |
0.6959 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6957 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6957 |
Remote Similarity |
NPD4535 |
Phase 3 |
0.6957 |
Remote Similarity |
NPD3750 |
Approved |
0.6957 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.6949 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6948 |
Remote Similarity |
NPD7095 |
Approved |
0.6946 |
Remote Similarity |
NPD7411 |
Suspended |
0.6946 |
Remote Similarity |
NPD6072 |
Discontinued |
0.6933 |
Remote Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD7041 |
Phase 2 |
0.6933 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6929 |
Remote Similarity |
NPD968 |
Approved |
0.6923 |
Remote Similarity |
NPD4140 |
Approved |
0.6918 |
Remote Similarity |
NPD3539 |
Phase 1 |
0.6918
|
Remote Similarity |
NPD2935 |
Discontinued |